Skip to main content
. 2021 Feb 15;112(3):1048–1059. doi: 10.1111/cas.14816

FIGURE 1.

FIGURE 1

Expression of CD69, HLA‐DR, and PD1 in TDLNs and tumor in head and neck cancer patients. A, Percentage of CD4+ T cells, CD8+ T cells, and CD4/CD8 ratio among analyzed compartments. B, Expression of CD69, HLA‐DR, and PD1 within CD4+ T cells. C, Expression of CD69, HLA‐DR, and PD1 within CD8+ T cells. Red represents samples from patients with nodal metastases. *<.05, **<.01, ***<.001, **** <.0001